Patents Assigned to RECRO PHARMA, INC.
  • Nanoparticulate meloxicam formulations
    Patent number: 10471067
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: November 12, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 10463673
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: November 5, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Intranasal dexmedetomidine compositions and methods of use thereof
    Patent number: 9795559
    Abstract: The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.
    Type: Grant
    Filed: December 11, 2012
    Date of Patent: October 24, 2017
    Assignee: Recro Pharma, Inc.
    Inventors: Geraldine A. Henwood, Randall J. Mack, John Joseph Koleng, Jr., Christopher T. Sharr, Charles Alexander Freyer
  • Treatment or prevention of hypotension and shock
    Patent number: 9446025
    Abstract: The present invention relates to a method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof. In addition, the present invention relates to a method for the treatment of cardiopulmonary resuscitation, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: September 20, 2016
    Assignee: Recro Pharma, Inc.
    Inventors: Riitta Heino, Tiina Leino, Tarja Lehtimaki
  • Treatment or prevention of hypotension and shock
    Patent number: 9078883
    Abstract: The present invention relates to a method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof. In addition, the present invention relates to a method for the treatment of cardiopulmonary resuscitation, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: July 14, 2015
    Assignee: Recro Pharma, Inc.
    Inventors: Riitta Heino, Tiina Leino, Tarja Lehtimaki
  • TREATMENT OR PREVENTION OF HYPOTENSION AND SHOCK
    Publication number: 20140100257
    Abstract: The present invention relates to a method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof. In addition, the present invention relates to a method for the treatment of cardiopulmonary resuscitation, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof.
    Type: Application
    Filed: June 24, 2013
    Publication date: April 10, 2014
    Applicants: Recro Pharma, Inc., Orion Corporation
    Inventors: Riitta Heino, Tiina Leino, Tarja Lehtimaki
  • INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20130178465
    Abstract: The present invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, and uses thereof.
    Type: Application
    Filed: December 11, 2012
    Publication date: July 11, 2013
    Applicant: RECRO PHARMA, INC.
    Inventor: Recro Pharma, Inc.
  • Treatment or prevention of hypotension and shock
    Patent number: 8470862
    Abstract: A method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof, and a method for the treatment of cardiopulmonary resuscitation, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: June 25, 2013
    Assignee: Recro Pharma, Inc.
    Inventors: Riitta Heino, Tiina Leino, Tarja Lehtimäki
  • TOPICAL TRANSDERMAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20130072532
    Abstract: Analgesic topical formulations of dexmedetomidine and methods of use thereof in the treatment and management of pain and other conditions.
    Type: Application
    Filed: January 7, 2011
    Publication date: March 21, 2013
    Applicant: Recro Pharma, Inc.
    Inventors: Geraldine A. Henwood, Randall J. Mack, Christopher T. Sharr, John J. Koleng, JR.
  • SUBLINGUAL DEXMEDITOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20110021588
    Abstract: Analgesic sublingual formulations of dexmedetomidine and methods of use thereof are provided for use in the prevention, treatment and management of pain and other conditions.
    Type: Application
    Filed: May 17, 2010
    Publication date: January 27, 2011
    Applicant: RECRO PHARMA, INC.
    Inventors: Geraldine Anne Henwood, Randall Jerome Mack, Christopher T. Sharr, John Koleng